[1] Sato T, Minatsuki S .Neuregulin-4, an adipokine, as a residual risk factor of atherosclerotic coronary artery disease[J]. Int Heart J, 2019, 60(1):1-3. [2] Capodanno D, Angiolillo DJ .Antithrombotic therapy for atherosclerotic cardiovascular disease risk mitigation in patients with coronary artery disease and diabetes mellitus[J]. Circulation, 2020, 142(22):2172-2188. [3] 雷琼, 何平平, 彭婷,等. 冠心病急诊PCI术后患者健康赋权的现状及影响因素[J]. 中南医学科学杂志, 2022,50(2):279-282. [4] Iadf A, Ndala B, Gbdsj C, et al.Novel biomarkers in the prognosis of patients with atherosclerotic coronary artery disease[J]. Revista Portuguesa de Cardiologia (English Edition), 2020, 39(11):667-672. [5] 徐以康, 杨洋, 刘旭. 冠心病射血分数中间值心力衰竭患者经皮腔内冠状动脉介入治疗术后效果分析[J]. 宁夏医科大学学报, 2022,44(7):728-732. [6] Deng W, Peng L, Yu J, et al. Characteristics of coronary artery atherosclerotic plaques in chronic kidney disease:Evaluation with coronary CT angiography[J]. Clin Radiol, 2019, 74(9):731.e1-731.e9. [7] Heianza Y, Ma W, Didonato JA, et al.Long-term changes in gut microbial metabolite trimethylamine N-oxide and coronary heart disease risk[J]. J Am Coll Cardiol, 2020, 75(7):763-772. [8] 谭鑫, 耿嘉逸, 李浩宇,等. 血清ICAM1和LDH活性水平在冠心病不同严重程度血管病变中的变化[J]. 海南医学院学报, 2021, 27(18):1368-1373. [9] 张国英. 血清HIF-1α和VEGF与冠心病严重程度的相关性[J]. 中西医结合心脑血管病杂志, 2021, 19(5):879-880. [10] 中华医学会心血管病学分会, 中国康复医学会心血管病专业委员会, 中国老年学学会心脑血管病专业委员会. 冠心病康复与二级预防中国专家共识[J]. 中华心血管病杂志, 2013, 41(4):267-275. [11] Cainzos-Achirica M, Glassner K, Zawahir HS, et al. Inflammatory bowel disease and atherosclerotic cardiovascular disease[J]. J Am Coll Cardiol, 2020, 76(24):2895-2905. [12] 祁冬, 何兴义, 姚木子,等. 基于冠状动脉CT血管成像的血流储备分数诊断心肌缺血的研究进展[J]. 江苏大学学报:医学版, 2022, 32(1):88-92. [13] 袁鹰, 何平, 汤祥瑞,等. 血清脂滴蛋白5,抗凋亡多肽和血清视黄醇结合蛋白4表达水平与冠心病严重程度的相关性[J]. 中西医结合心脑血管病杂志, 2021, 19(7):1148-1151. [14] Alam A, Levanduski E, Denz P, et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer[J]. Cancer Cell, 2022, 40(2):153-167.e11. [15] 开悦, 刘虎, 王文茜,等. 高脂饮食诱导肥胖小鼠白色脂肪组织中IL-33的表达及意义[J]. 中国免疫学杂志, 2021, 37(5):524-528. [16] Sandoval Y, Jaffe AS .Letter by sandoval and jaffe regarding article, “Temporal release of high-sensitivity cardiac troponin t and i and copeptin after brief induced coronary artery balloon occlusion in humans”[J]. Circulation, 2021, 144(9):e168. [17] Deranek AE, Baldo A, Schwartz SD, et al.Mappinga the cardiac troponint linker region to actin and determining pathogenic point mutationl effects[J]. Biophysical J, 2021, 120(3):250a. [18] Honda Y, Mok Y, Ishigami J,et al.The fifth-generation cardiac troponin t and cardiovascular disease in the community[J]. J Am Coll Cardiol, 2021, 78(20):2019-2021. [19] 谭鑫, 耿嘉逸, 李浩宇,等. 血清ICAM1和LDH活性水平在冠心病不同严重程度血管病变中的变化[J]. 海南医学院学报, 2021, 27(18):1368-1373. [20] 李盼,马冰新,郑云辉,等.急性脑梗死患者Mb、Glu及LDH水平与神经功能缺损的关系[J].分子诊断与治疗杂志,2022,14(10):1815-1818. |